Calibration parameters to adjust baseline survival of screen-detected non-small-cell cancers to match stage-specific survival curves and reported mortality reductions in National Lung Screening Trial (NLST)
|Stage of screen-detected cancer||Relative risk applied to baseline survival||Lead-time redistribution scalarsNote *|
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: